Recently an important paper — one which had the potential to revolutionize the treatment of type 1 diabetes — was retracted because its results could not be replicated. Far from being a negative incident, this is the way that science should be done.
Erectile Dysfunction (ED) adversely impacts over 30 million men in the United States to some extent. Depending upon the cause, treatment options can be limited. Traditionally as a last resort when a man is ineligible or has failed less invasive alternatives, surgical insertion of a penile implant is considered. Promising technology responsive to heat was recently tested and published.
A new study published in JAMA details the U.S. county-level trends in mortality rates for major causes of death. While a bit flawed, it's a step in the right direction as regional health disparity is often way more vital to informing policy than national tendencies.
Are the very real physical costs of your outrage worth it? Albeit the election, contentious divorce or nonstop negativity, there are tangible prices to our responses to these and other types of triggers.
Last Monday marked the first debate of of three Clinton-Trump debates. Though no fits of any kind -- coughing or otherwise -- were thrown, the two presidential candidates did throw many jabs, as expected. But when Trump said her Democratic rival "doesn't have the stamina," it eventually led us to this question: Who does have the stamina?
Insulin-requiring diabetics may be able to toss their syringes in the not-too-distant future, if a new type of insulin-containing pill can conquer research hurdles. Packaging the hormone in a new type of lipid vesicle could protect it from breakdown by stomach acid and eliminate the need for frequent injections.
Having Type 1 diabetes means a person's insulin-producing beta cells don't work normally. New research brings us closer to the day that new, functional beta cells can be produced in the lab and given to diabetics to normalize their metabolism.
For years, we've been getting advice to lower our consumption of fat to help prevent obesity and related ills. But a new study suggests that one group of fats — those found in whole milk — might actually have health benefits.
For the very overweight and the obese, gastric bypass surgery has essentially become a game-changer, and in some cases, a life-saver. While the operation has enjoyed this type of widespread success for the very obese, is it also reasonable to use it for those with lesser degrees of obesity? A new, small study says yes.
Bariatric surgery is probably the most effective means of dealing with obesity, and with obesity-linked Type 2 diabetes as well. Some questions remain like, how long do benefits last and who should be eligible for this treatment? A couple of new reports shed some light.
What if a diabetes sufferer, who needs insulin to manage the condition, loses their insurance or can't afford the co-pays. It is possible to buy the drug instead, without a prescription and over the counter, much as one might buy ibuprofen or aspirin? It is, but is this a good idea? It's not clear cut either way.
Bariatric surgery is probably the most successful means of reducing body weight (and fatness) in obese people. But Body Mass Index is not necessarily the best predictor of diabetes remission with the stomach surgery, although it has been the main criterion of eligibility for it.